Home / Stocks / CABA

CABA insider trading

Cabaletta Bio, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
8
Bought · 24 mo
$296k
Buys · last 90 days
0 · $0
Most recent buy
2026-01-21

Cluster buy detected

8 insiders bought CABA within a short window (2026-01-21), $296k in total — cluster score 81/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-01-21Chang David J.cluster
Chief Medical Officer
Bought8,800$2.26$20k
2026-01-21Binder Gwendolyncluster
President, Science & Tech.
Bought11,312$2.19$25k
2026-01-21Tomasello Shawncluster
Director
Bought22,725$2.21$50k
2026-01-21Gavel Stevecluster
Chief Commercial Officer
Bought22,170$2.27$50k
2026-01-21Bollard Catherinecluster
Director
Bought4,405$2.27$10k
2026-01-21Nichtberger Stevencluster
President & CEO
Bought45,000$2.24$101k
2026-01-21Simon Markcluster
Director
Bought11,061$2.28$25k
2026-01-21Gerard Michaelcluster
General Counsel
Bought6,600$2.27$15k

Most active insider buyers

InsiderRoleBuysTotal bought
Nichtberger StevenPresident & CEO1$101k
Gavel SteveChief Commercial Officer1$50k
Tomasello ShawnDirector1$50k
Simon MarkDirector1$25k
Binder GwendolynPresident, Science & Tech.1$25k
Chang David J.Chief Medical Officer1$20k

See CABA on the chart

Every insider buy and sell for CABA plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.